141 related articles for article (PubMed ID: 9780850)
41. The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases.
Miyazaki M
Angiology; 1995 Jan; 46(1):53-8. PubMed ID: 7818157
[TBL] [Abstract][Full Text] [Related]
42. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Momose T; Matsui T; Kosaka N; Ohtake T; Watanabe T; Nishikawa J; Abe K; Tanaka J; Takakura K; Iio M
Radiat Med; 1989; 7(5):243-6. PubMed ID: 2629037
[TBL] [Abstract][Full Text] [Related]
43. Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat.
Rischke R; Krieglstein J
Pharmacology; 1990; 41(3):153-60. PubMed ID: 2277809
[TBL] [Abstract][Full Text] [Related]
44. Pathophysiology of the human brain after stroke, monitored by positron emission tomography.
Gjedde A
Exp Pathol; 1991; 42(4):221-7. PubMed ID: 1959582
[TBL] [Abstract][Full Text] [Related]
45. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.
Segel SA; Fanelli CG; Dence CS; Markham J; Videen TO; Paramore DS; Powers WJ; Cryer PE
Diabetes; 2001 Aug; 50(8):1911-7. PubMed ID: 11473055
[TBL] [Abstract][Full Text] [Related]
46. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
Murashko NK
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):51-5. PubMed ID: 18427520
[TBL] [Abstract][Full Text] [Related]
47. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study.
Baron JC; Rougemont D; Soussaline F; Bustany P; Crouzel C; Bousser MG; Comar D
J Cereb Blood Flow Metab; 1984 Jun; 4(2):140-9. PubMed ID: 6609928
[TBL] [Abstract][Full Text] [Related]
48. Role of vinpocetine in cerebrovascular diseases.
Patyar S; Prakash A; Modi M; Medhi B
Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
[TBL] [Abstract][Full Text] [Related]
49. Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles.
Bian X; Yang L; Jiang D; Grippin AJ; Ma Y; Wu S; Wu L; Wang X; Tang Z; Tang K; Pan W; Dong S; Kim BYS; Jiang W; Yang Z; Li C
Nat Commun; 2024 May; 15(1):3987. PubMed ID: 38734698
[TBL] [Abstract][Full Text] [Related]
50. Eburnamine derivatives and the brain.
Vas A; Gulyás B
Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
[TBL] [Abstract][Full Text] [Related]
51. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
[TBL] [Abstract][Full Text] [Related]
52. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of cerebral vasoreactivity by SPECT and transcranial Doppler sonography using the acetazolamide test.
Pávics L; Grünwald F; Barzó P; Ambrus E; Menzel C; Schomburg A; Borda L; Máté E; Bodosi M; Csernay L
Nuklearmedizin; 1994 Dec; 33(6):239-43. PubMed ID: 7854920
[TBL] [Abstract][Full Text] [Related]
54. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
Tune L; Brandt J; Frost JJ; Harris G; Mayberg H; Steele C; Burns A; Sapp J; Folstein MF; Wagner HN
Acta Psychiatr Scand Suppl; 1991; 366():61-5. PubMed ID: 1897377
[TBL] [Abstract][Full Text] [Related]
55. [The effect of kavinton, trental, sermion and kurantil on the blood flow rate in individual segments of the cerebral arteries].
Eninia GI; Purinia IV; Timofeeva TN
Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):13-5. PubMed ID: 7912024
[TBL] [Abstract][Full Text] [Related]
56. [The state of cerebral blood flow in hypertensive crises and possibilities of its correction].
Nevzorova VA; Zakharchuk NV; Plotnikova IV
Kardiologiia; 2007; 47(12):20-3. PubMed ID: 18260974
[TBL] [Abstract][Full Text] [Related]
57. Serial evaluation of acute cerebral hyperperfusion by transcranial color-coded sonography.
Fujimoto S; Toyoda K; Hirai Y; Uwatoko T; Yasumori K; Inoue T; Ibayashi S; Okada Y
Ultrasound Med Biol; 2006 May; 32(5):659-64. PubMed ID: 16677925
[TBL] [Abstract][Full Text] [Related]
58. Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography.
Heiss WD; Holthoff V; Pawlik G; Neveling M
J Cereb Blood Flow Metab; 1990 Jan; 10(1):127-32. PubMed ID: 2298828
[TBL] [Abstract][Full Text] [Related]
59. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
[TBL] [Abstract][Full Text] [Related]
60. Assessment of pathophysiology of stroke by positron emission tomography.
Heiss WD; Herholz K
Eur J Nucl Med; 1994 May; 21(5):455-65. PubMed ID: 8062853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
